Publications
Print PDF
The Center for Biosimilars Interview: Axinn’s Landmon Provides an Expert Legal Opinion on HHS’ Drug Price Strategy
September 22, 2021
The Center for Biosimilars

Axinn partner Chad Landmon participated in a video interview with The Center for Biosimilars, where he discussed HHS’ Drug Price Strategy.

Click here to access the interview.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.